Friday, September 1, 2023 Daily Archives

Lonza breaks ground on Vertex diabetes cell therapy plant

by

CDMO Lonza began work this week on the 130,000 square-foot facility set to support Vertex’s cell therapies for type 1 diabetes. A groundbreaking ceremony was held this week for the dedicated facility, first announced in June, located adjacent to Lonza’s campus in Portsmouth, New Hampshire. The dedicated facility will support Vertex’s type 1 diabetes candidates, including VX-880, fresh from producing positive results in an ongoing Phase I/II study. VX-880 is an investigative allogeneic cell therapy, acquired through the Semma Therapeutics…

September 1, 2023

Gingko heads into the Cloud for AI drug development

by

Large language models capable of generating ChatGPT-style information could accelerate drug discovery and development, says Ginkgo Bioworks as it inks a five-year deal with Google. The agreement sees Gingko commit to paying Google a minimum of $289 million over five years to purchase cloud hosting services in exchange for various discounts on such services. The firm will use the technology to develop large language models (LLMs) running on Google Cloud’s Vertex AI platform to aid customers accelerate discovery and development…

September 1, 2023